Suraksha Diagnostic Ltd. (SURAKSHA.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-74.2%

₹83.46

vs ₹323.30 price

Levered DCF

₹72.44

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021
P/E	36.89×	43.7×	92.06×	334.36×	145.63×	280.5×
P/B	4.85×	6.74×	12.13×	13.96×	14.93×	17.65×
P/S	3.82×	5.65×	9.95×	11.45×	9.75×	15.91×
EV / EBITDA	13.47×	17.75×	31.09×	47.84×	34.84×	90.45×
Gross margin	57.7%	88.3%	87.5%	40.1%	38.7%	76.5%
Operating margin	17.5%	19.1%	18.7%	8.2%	16.4%	48.2%
Net margin	10.4%	12.6%	10.8%	3.4%	9.3%	4.6%
Current ratio	1.05×	1.1×	1.84×	1.77×	1.64×	1.1×
Debt / equity	0.53×	0.42×	0.5×	0.62×	0.68×	0.13×
Interest coverage	4.33×	5.74×	4.25×	1.63×	3.89×	71.13×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021
Return on equity	13.1%	15.1%	13.2%	4.2%	14.3%	5.1%
Return on invested capital	9.5%	11.8%	10.9%	5.4%	10.7%	44.2%
Return on assets	7.2%	9.5%	7.9%	2.3%	7.5%	3.8%
Free cash flow yield	1.4%	1.5%	0.7%	1.4%	1.8%	0.4%
Earnings yield	2.7%	2.2%	1.1%	0.3%	1.0%	0.3%
Enterprise value	₹12.9B	₹15.1B	₹22.6B	₹22.7B	₹22.7B	₹22.4B
Net debt / EBITDA	1.08×	1.02×	1.21×	1.99×	1.48×	0.54×
Cash conversion cycle (days)	-9	-49	-89	-96	-34	-75